Advertisement

Topics

CureVac AG Company Profile

07:26 EST 16th December 2018 | BioPortfolio

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The company applies its technologies for the development of cancer therapies, prophylactic vaccines and molecular therapies.


News Articles [14 Associated News Articles listed on BioPortfolio]

CureVac enters clinical phase with mRNA vaccine

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced the initiation of its Phase I dose-escalation clinical trial with the novel mRNA-base...

Die Universität Tübingen verleiht die Ehrensenatorenwürde an Dr. Ingmar Hoerr, Mitgründer und Aufsichtsratsvorsitzenden der CureVac AG

TÜBINGEN, Deutschland und BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Das biopharmazeutische Unternehmen CureVac AG, Pionier im Bereich mRNA-basierter Impfstoffe und Therapeutika, gratuliert Dr. Ingm.....

CureVac AG: CureVac präsentiert vorläufige Daten seiner Phase-I-Studie mit dem RNA-basierten Wirkstoff CV8102 zur intratumoralen Anwendung auf der 33. Jahrestagung der Society for Immunotherapy of Cancer

Die Daten umfassen CV8102 als Einzelwirkstoff und in Kombination mit einer Anti-PD1-Therapie TÜBINGEN, Deutschland / BOSTON, USA, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Das biopharmazeutische Unternehme.....

Q&A: mRNA’s place in vaccine manufacturing with CureVac

Messenger RNA is demonstrating success in vaccine manufacturing and CureVac is giving it the place to do so with the development of a prophylactic vaccine with mRNA at its core.

Curevac reports another failed cancer vaccine

CureVac inks $1.7bn deal on mRNA cancer vaccines

CureVac to Present at the 19th Annual Piper Jaffray Healthcare Conference

TÜBINGEN, Germany and BOSTON, Nov. 21, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichel...

CureVac Announces Appointment of Matthew L. S. Beck as Vice President of Investor Relations

TÜBINGEN, Germany and BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced the appointment o...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

Rabies infection is a disease that is caused by a virus and which is transmitted in many countries by rabid animals (dogs, monkeys, bats, etc.) through bites, scratches or licking of wound...

Companies [3 Associated Companies listed on BioPortfolio]

CureVac AG

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing this versatile molecule for medical...

The International mRNA Health Conference

The International mRNA Health Conference brings together top scientists and professionals from all around the world to discuss the rapidly growing field of mRNA while fostering or...

CureVac GmbH

We are dedicated to offering reliable and innovative RNA related products and services to the Life Science Community. siRNA [order here]: ultrapure (HPLC purified)For the design of siRNA please use EM...

More Information about "CureVac AG" on BioPortfolio

We have published hundreds of CureVac AG news stories on BioPortfolio along with dozens of CureVac AG Clinical Trials and PubMed Articles about CureVac AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CureVac AG Companies in our database. You can also find out about relevant CureVac AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record